Get startedLog in
    Picture of SCHOTT Pharma AG & Co KgaA logo

    1SXP — SCHOTT Pharma AG & Co KgaA Cashflow Statement

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousMid CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for SCHOTT Pharma AG & Co KgaA, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

    2021
    September 30th
    2022
    September 30th
    2023
    September 30th
    C2024
    September 30th
    2025
    September 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:——
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line101126152150147
    Depreciation
    Deferred Taxes
    Non-Cash Items9.8625-2.1-2.471.97
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-17-27.3-15.716.1-50.5
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities132182182225180
    Capital Expenditures-98.6-153-176-145-145
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items2.7310.64.11-110-14.3
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-95.9-142-171-255-159
    Financing Cash Flow Items-26-40.91158.17.81
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-27.5-42.4-11.431.9-21.1
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash9.250.935-4.44-1.18-0.712